Lipids attribution for controls and dengue groups according with Lipid Maps database, obtained via exploratory metabolomics from human serum.

Lipids attribution for controls and dengue groups according with Lipid Maps database, obtained via exploratory metabolomics from human serum.

<p>Lipids attribution for controls and dengue groups according with Lipid Maps database, obtained via exploratory metabolomics from human serum.</p>

Na minha lista:

Detalhes bibliográficos
Autor principal:	Ricardo E. Correa Fierro (22676430) (author)
Outros Autores:	Noroska Gabriela Mogollón Salazar (22676433) (author), Washington B. Cárdenas (3213597) (author), Evencio Joel Medina-Villamizar (22676436) (author), Jefferson Pastuña-Fasso (22676439) (author), Melanie Ochoa-Ocampo (21222826) (author), Giovanna Morán-Marcillo (22676442) (author), Mary Ernestina Regato Arrata (22676445) (author), Mildred Zambrano (16641645) (author), Joyce Andrade (16641648) (author), Juan Chang (8280894) (author), Saurabh Mehta (367781) (author), Fernanda Bertuccez Cordeiro (16641642) (author)
Publicado em:	2025
Assuntos:	Biochemistry Medicine Microbiology Cell Biology Biotechnology Cancer Virology Biological Sciences not elsewhere classified Chemical Sciences not elsewhere classified receiver operating characteristic highest predictive power faster patient screening component 5 showing complex immune response serum lipid metabolome evaluate biomarker performance denv ), triggers serum lipidomics profiling new diagnostic tools div >< p disproportionately affects children assess group separation pediatric dengue fever dengue virus infection denv infected group dengue virus dengue fever lipid metabolism diagnostic methods diagnosis tools dengue research biomarker potential biomarker discovery z </ subtropical regions metabolic alterations may contribute mass spectrometry key role glycerol lipids fatty acids despite advancements curve analysis adolescents infected 68345 ). 15 ).
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados

PLS-DA regression model from untargeted metabolomics of serum samples from children infected with dengue and controls.
por: Ricardo E. Correa Fierro (22676430)
Publicado em: (2025)

ROC curve analysis of a set of biomarkers obtained via untargeted metabolomics in serum samples from children infected with DENV compared to Control.
por: Ricardo E. Correa Fierro (22676430)
Publicado em: (2025)

Univariate ROC curves for individual analysis of the 15 <i>m/z</i> suggested as biomarkers.
por: Ricardo E. Correa Fierro (22676430)
Publicado em: (2025)

Workflow of untargeted metabolomics in serum samples from children infected with DENV.
por: Ricardo E. Correa Fierro (22676430)
Publicado em: (2025)

Supplementary Figure S1 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
por: Sarita Paudel (15047430)
Publicado em: (2025)

Supplementary Figure S2 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
por: Sarita Paudel (15047430)
Publicado em: (2025)

Supplementary Figure S3 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
por: Sarita Paudel (15047430)
Publicado em: (2025)

Supplementary Figure S4 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
por: Sarita Paudel (15047430)
Publicado em: (2025)

Supplementary Figure S5 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
por: Sarita Paudel (15047430)
Publicado em: (2025)

Supplementary Figure S6 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
por: Sarita Paudel (15047430)
Publicado em: (2025)

Data Sheet 1_Adaptive laboratory evolution enhances cell yield and lipid production of Chlorella sorokiniana under mildly cold conditions.pdf
por: Shu-Yi Lu (22679327)
Publicado em: (2025)

Figure 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
por: James R. Larkin (14936324)
Publicado em: (2025)

Figure 2 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
por: James R. Larkin (14936324)
Publicado em: (2025)

Figure 3 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
por: James R. Larkin (14936324)
Publicado em: (2025)

Figure 4 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
por: James R. Larkin (14936324)
Publicado em: (2025)

Figure 5 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
por: James R. Larkin (14936324)
Publicado em: (2025)

Table 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms
por: James R. Larkin (14936324)
Publicado em: (2025)

A Four-Gene Signature from Blood to Exclude Bacterial Etiology of Lower Respiratory Tract Infection in Adults
por: Edward E. Walsh (20760337)
Publicado em: (2025)

Supplementary Table S3 from Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma
por: Jun Wang (15051911)
Publicado em: (2025)

Lipid residency distributions during coarse-grained simulations of YbbAP.
por: Martin B. L. McAndrew (22683641)
Publicado em: (2025)

Molecular dynamics simulations of YbbAP suggest the periplasmic-side pocket is a lipid-binding site.
por: Martin B. L. McAndrew (22683641)
Publicado em: (2025)

Atomistic molecular dynamics simulation showing partial extraction of a lipid from the bilayer by YbbAP.
por: Martin B. L. McAndrew (22683641)
Publicado em: (2025)

Supplementary Figure S1 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
por: Javier Pascual (15018176)
Publicado em: (2025)

Supplementary Figure S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
por: Javier Pascual (15018176)
Publicado em: (2025)

Supplementary Figure S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
por: Javier Pascual (15018176)
Publicado em: (2025)

Supplementary Figure S4 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
por: Javier Pascual (15018176)
Publicado em: (2025)

Supplementary Figure S5 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
por: Javier Pascual (15018176)
Publicado em: (2025)

Supplementary Table S2 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
por: Javier Pascual (15018176)
Publicado em: (2025)

Supplementary Table S3 from Baseline Mutations and ctDNA Dynamics as Prognostic and Predictive Factors in ER-Positive/HER2-Negative Metastatic Breast Cancer Patients
por: Javier Pascual (15018176)
Publicado em: (2025)

Relationship between estimated probability of a dengue virus infection (DENV) found during model testing for Model 9 (incorporating paired IgG, IgM, GM HAI, and acute GM HAI serological data) and the number of serological assays (RT-PCR, HAI, and EIA) that interpret the individual as having an infection.
por: Marco Hamins-Puértolas (15238661)
Publicado em: (2025)

Table 1_Cross-species validation of a 6-miRNA blood signature for Parkinson’s disease: from MPTP mice to human PBMC and serum exosomes.docx
por: Nagyum Jung (22686458)
Publicado em: (2025)

Figure 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
por: Nicola S. Meagher (15048462)
Publicado em: (2025)

Figure 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
por: Nicola S. Meagher (15048462)
Publicado em: (2025)

Figure 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
por: Nicola S. Meagher (15048462)
Publicado em: (2025)

Supplementary Tables S1-S11 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
por: Nicola S. Meagher (15048462)
Publicado em: (2025)

Table 1 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
por: Nicola S. Meagher (15048462)
Publicado em: (2025)

Table 2 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
por: Nicola S. Meagher (15048462)
Publicado em: (2025)

Table 3 from Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes
por: Nicola S. Meagher (15048462)
Publicado em: (2025)

Spearman correlation coefficient (r<sub>s</sub>) between echocardiographic measurements (i.e., left atrial:aortic root diameter; LA:Ao), markers of loss of GI barrier function (i.e., lipopolysaccharide; LPS), and cardiac (i.e., troponin) and systemic (i.e., cytokines) inflammation in 36 dogs with untreated myxomatous mitral valve disease (MMVD).
por: Maria C. Jugan (18928389)
Publicado em: (2025)

Association between Exposures of Interest with Serum Lipopolysaccharide and Troponin Concentrations Based on Univariable Models‡ in 36 Client-owned Dogs with Untreated Myxomatous Mitral Valve Disease (MMVD).
por: Maria C. Jugan (18928389)
Publicado em: (2025)

Cannot write session to /tmp/vufind_sessions/sess_cfos0eat36b4ehif7st94d7p3c